6420_CD
Annual_JJ
Report_NN
2005_CD
._.
qxd_NN
28_CD
4_CD
06_CD
17:44_CD
Page_NN
108_CD
Notes_NN
to_PIN
the_DT
Company_NN
financial_JJ
statements_NOMZ
UK_NN
GAAP_NN
As_IN
at_PIN
December_NN
31_CD
,_,
2005_CD
A_DT
Presentation_NOMZ
of_PIN
the_DT
financial_JJ
statements_NOMZ
Directors_NN
emoluments_NOMZ
and_PHC
employees_NN
Details_NN
of_PIN
Directors_NN
remuneration_NOMZ
can_POMD
be_VB [PASS]
found_VBN [PRIV]
in_PIN
Note_NN
37_CD
and_CC
the_DT
Description_NOMZ
of_PIN
the_DT
business_NOMZ
Directors_NN
Remuneration_NOMZ
Report_NN
of_PIN
the_DT
Group_NN
accounts_NN
._.
There_EX
was_VBD
The_DT
Company_NN
was_VBD [PASS]
incorporated_VBN
as_IN
Trushelfco_NN
No._NN
._.
3167_CD
Limited_JJ
on_PIN
one_CD
employee_NN
of_PIN
the_DT
Company_NN
in_PIN
the_DT
period_NN
period_NN
June_NN
27_CD
,_,
2005_CD
June_NN
27_CD
,_,
2005_CD
._.
On_PIN
September_NN
6_CD
,_,
2005_CD
the_DT
Company_NN
was_VBD [PASS]
re-registered_VBN
to_PIN
September_NN
5_CD
,_,
2005_CD
:_:
no_SYNE
employees_NN
._.
as_IN
a_DT
public_JJ
limited_JJ
company_NN
and_CC
changed_VBD
its_PIT
name_NN
to_PIN
Trushire_NN
plc._NN
._.
On_PIN
September_NN
12_CD
,_,
2005_CD
the_DT
Company_NN
changed_VBD
its_PIT
name_NN
to_PIN
Shire_NN
plc._NN
._.
Details_NN
of_PIN
the_DT
Groups_NN
share_NN
option_NOMZ
schemes_NN
are_VPRT [PASS]
contained_VBN
in_PIN
the_DT
Note_NN
31_CD
of_PIN
the_DT
Group_NN
accounts_NN
._.
The_DT
charge_NN
recorded_VBN [WZPAST]
by_PIN
the_DT
Company_NN
during_PIN
Shire_NN
plc_NN
is_VPRT [BEMA]
the_DT
parent_NN
company_NN
of_PIN
the_DT
Shire_NN
Group_NN
,_,
the_DT
principal_JJ
activity_NOMZ
the_DT
period_NN
is_VPRT
$_$
76,000_CD
period_NN
from_PIN
June_NN
27_CD
,_,
2005_CD
to_PIN
September_NN
5_CD
,_,
2005_CD
:_:
of_PIN
which_WDT [PIRE]
is_VPRT [BEMA]
the_DT
research_NN
,_,
development_NOMZ
and_PHC
marketing_GER
of_PIN
prescription_NOMZ
$_$
nil_JJ
relating_VBG
to_PIN
one_CD
director_NN
,_,
being_VBG [PRESP] [BEMA]
an_DT
apportionment_NOMZ
of_PIN
the_DT
group_NN
medicines_NN
._.
The_DT
Group_NN
focuses_VPRT
on_PIN
four_CD
therapeutic_JJ
areas_NN
:_:
CNS_NN
,_,
GI_NN
,_,
charge_NN
._.
The_DT
auditors_NN
remuneration_NOMZ
was_VBD
$_$
22,891_CD
period_NN
June_NN
27_CD
,_,
2005_CD
to_PIN
Preparation_NOMZ
of_PIN
financial_JJ
statements_NOMZ
September_NN
5_CD
,_,
2005_CD
:_:
nil_NN
._.
These_DEMO
financial_JJ
statements_NOMZ
are_VPRT [PASS]
drawn_VBN
up_RP
in_PIN
accordance_NN
with_PIN
UK_NN
Generally_RB
Accepted_JJ
Accounting_GER
Practice_NN
UK_NN
GAAP_NN
as_IN
at_PIN
December_NN
31_CD
,_,
2005_CD
,_,
with_PIN
comparative_JJ
figures_NN
for_PIN
the_DT
period_NN
from_PIN
incorporation_NOMZ
B_NN
Accounting_GER
policies_NN
on_PIN
June_NN
27_CD
,_,
2005_CD
to_PIN
September_NN
5_CD
,_,
2005_CD
._.
Intangible_JJ
assets_NN
brand_NN
name_NN
As_IN
permitted_VBN
by_PIN
section_NOMZ
230_CD
of_PIN
the_DT
Companies_NN
Act_NN
1985_CD
,_,
the_DT
profit_NN
and_CC
Intangible_JJ
assets_NN
comprise_VPRT
the_DT
cost_NN
of_PIN
acquiring_VBG
a_DT
brand_NN
name_NN
,_,
which_WDT [SERE]
loss_NN
account_NN
of_PIN
the_DT
Company_NN
is_VPRT [PASS]
not_XX0
presented_VBN
in_PIN
this_DEMO
annual_JJ
report_NN
._.
has_VPRT [PEAS]
not_XX0
been_VBN [PASS]
amortised_VBN
as_IN
the_DT
end_NN
of_PIN
its_PIT
useful_JJ
economic_JJ
life_NN
can_POMD
not_XX0
The_DT
Company_NN
reported_VBD [PUBV]
a_DT
loss_NN
for_PIN
the_DT
period_NN
from_PIN
September_NN
5_CD
,_,
2005_CD
be_VB [PASS]
foreseen_VBN
._.
Provision_NN
is_VPRT [PASS]
made_VBN
for_PIN
any_QUAN
impairment_NOMZ
._.
Investments_NOMZ
Investments_NOMZ
held_VBD [PRIV]
as_IN
fixed_JJ
assets_NN
are_VPRT [PASS]
stated_VBN [PUBV]
at_PIN
cost_NN
or_CC
,_,
if_COND
applicable_JJ
On_PIN
November_NN
25_CD
,_,
2005_CD
the_DT
Company_NN
became_VBD
the_DT
holding_VBG [PRIV]
company_NN
under_IN
section_NOMZ
131_CD
of_PIN
the_DT
Companies_NN
Act_NN
1985_CD
,_,
the_DT
nominal_JJ
value_NN
of_PIN
of_PIN
Shire_NN
Pharmaceuticals_NN
Group_NN
plc_NN
SPG_NN
pursuant_JJ
to_PIN
a_DT
scheme_NN
of_PIN
the_DT
shares_NN
issued_VBN
,_,
less_JJ
any_QUAN
provision_NN
for_PIN
impairment_NOMZ
._.
arrangement_NOMZ
under_IN
section_NOMZ
425_CD
of_PIN
the_DT
UK_NN
Companies_NN
Act_NN
1985_CD
that_DEMP
was_VBD [BYPA]
approved_VBN
by_PIN
the_DT
High_NN
Court_NN
of_PIN
Justice_NN
in_PIN
England_NN
and_PHC
Wales_NN
and_CC
Exchangeable_JJ
shares_NN
the_DT
shareholders_NN
of_PIN
SPG_NN
the_DT
Scheme_NN
of_PIN
Arrangement_NOMZ
._.
Further_JJ
details_NN
The_DT
exchangeable_JJ
shares_NN
are_VPRT [PASS]
included_VBN
as_IN
part_NN
of_PIN
share_NN
capital_NN
in_PIN
the_DT
are_VPRT [BEMA]
in_PIN
Note_NN
H._NN
Companys_NN
balance_NN
sheet_NN
to_TO
present_VB
a_DT
true_JJ
and_PHC
fair_JJ
view_NN
of_PIN
the_DT
Companys_NN
capital_NN
structure_NN
,_,
which_WDT [SERE]
differs_VPRT
from_PIN
the_DT
Companies_NN
Act_NN
As_CONJ
a_NULL
consequence_NULL
of_PIN
the_DT
Scheme_NN
of_PIN
Arrangement_NOMZ
,_,
the_DT
Companys_NN
1985_CD
requirements_NOMZ
to_TO
reflect_VB [PRIV]
these_DEMO
amounts_NN
as_IN
minority_NOMZ
interests_NN
,_,
functional_JJ
currency_NN
and_CC
presentational_JJ
currency_NN
is_VPRT [BEMA]
now_TIME
the_DT
US_FPP1
Dollar_NN
as_IN
they_TPP3
will_PRMD
become_VB
,_,
and_ANDC
are_VPRT [BEMA]
equivalent_PRED
,_,
to_PIN
ordinary_JJ
shares_NN
._.
Comparatives_NN
have_VPRT [SPAU] [PEAS]
accordingly_RB
been_VBN [PASS]
restated_VBN
using_VBG
the_DT
exchange_NN
rate_NN
prevailing_VBG [WZPRES]
at_PIN
September_NN
5_CD
,_,
2005_CD
._.
Dividends_NN
paid_VBD
and_PHC
received_VBD
Dividend_NN
distribution_NOMZ
to_PIN
the_DT
Companys_NN
shareholders_NN
is_VPRT [PASS]
recognized_VBN [PRIV]
as_IN
Accounting_GER
convention_NOMZ
and_PHC
standards_NN
a_DT
liability_NOMZ
in_PIN
the_DT
Companys_NN
financial_JJ
statements_NOMZ
in_PIN
the_DT
period_NN
in_PIN
which_WDT [PIRE]
The_DT
balance_NN
sheet_NN
has_VPRT [PEAS]
been_VBN [PASS]
prepared_VBN
under_IN
the_DT
historical_JJ
cost_NN
the_DT
shareholders_NN
right_RB
to_TO
receive_VB
payment_NOMZ
is_VPRT [PASS]
established_VBN [PRIV]
._.
This_DEMP
occurs_VPRT
convention_NOMZ
and_PHC
complies_NN
with_PIN
applicable_JJ
UK_NN
accounting_GER
standards_NN
._.
in_PIN
the_DT
period_NN
in_PIN
which_WDT [PIRE]
the_DT
dividends_NN
are_VPRT [BYPA]
approved_VBN
by_PIN
the_DT
Companys_NN
shareholders_NN
,_,
or_CC
in_PIN
the_DT
case_NN
of_PIN
an_DT
interim_JJ
dividend_NN
,_,
when_RB
the_DT
dividend_NN
Accounting_GER
principles_NN
and_PHC
policies_NN
is_VPRT [PASS]
paid_VBN
._.
The_DT
preparation_NOMZ
of_PIN
the_DT
balance_NN
sheet_NN
in_PIN
conformity_NOMZ
with_PIN
UK_NN
GAAP_NN
requires_VPRT [SUAV]
management_NOMZ
to_TO
make_VB
estimates_NN
and_PHC
assumptions_NOMZ
that_TOBJ
Expenditure_NN
affect_VB
the_DT
reported_VBN [PUBV]
amounts_NN
of_PIN
assets_NN
and_PHC
liabilities_NOMZ
and_PHC
disclosure_NN
Expenditure_NN
is_VPRT [PASS]
recognized_VBN [PRIV]
in_PIN
respect_NN
of_PIN
goods_NN
and_PHC
services_NN
received_VBN [WZPAST]
of_PIN
contingent_JJ
assets_NN
and_PHC
liabilities_NOMZ
at_PIN
the_DT
balance_NN
sheet_NN
date_NN
._.
Actual_JJ
when_RB
supplied_VBN
in_PIN
accordance_NN
with_PIN
contractual_JJ
terms_NN
._.
Provision_NN
is_VPRT [PASS]
made_VBN
amounts_NN
could_POMD
differ_VB
from_PIN
those_DEMO
estimates_NN
._.
when_RB
an_DT
obligation_NOMZ
exists_VPRT
for_PIN
a_DT
future_JJ
liability_NOMZ
in_PIN
respect_NN
of_PIN
a_DT
past_JJ
event_NN
and_ANDC
where_RB
the_DT
amount_NN
of_PIN
the_DT
obligation_NOMZ
can_POMD
be_VB [SPAU] [PASS]
reliably_RB
estimated_VBN [PRIV]
._.
The_DT
balance_NN
sheet_NN
has_VPRT [PEAS]
been_VBN [PASS]
prepared_VBN
in_PIN
accordance_NN
with_PIN
the_DT
Companys_NN
accounting_GER
policies_NN
approved_VBN [WZPAST]
by_PIN
the_DT
Board_NN
and_CC
described_VBN
in_PIN
Note_NN
B._NN
108_CD
Annual_JJ
report_NN
and_PHC
accounts_NN
for_PIN
the_DT
year_NN
ended_VBD
December_NN
31_CD
,_,
2005_CD
Shire_NN
plc_NN
